Molecular imaging in prostate cancer can play the additional critical role of an early biomarker for response to therapy, similar to how 18F-FDG is used in other malignancies.
Akiva Mintz, MD, PhD, MHA
Advertisement
Articles by Akiva Mintz, MD, PhD, MHA
Advertisement
Latest Updated Articles
- PET/CT in Prostate Cancer: An Unmet Clinical Need
December 15th 2014
Advertisement
Advertisement
Trending on CancerNetwork
1
Supervised Keto Diet/Triplet Chemo Improves Survival in Pancreatic Cancer
2
What Does the Future Hold for Bispecific Antibodies in Multiple Myeloma?
3
Insights Across Hematologic Oncology at Columbia University
4
Managing PSMA-PET–Positive Oligometastatic Prostate Cancer
5